How many email patterns does Exeliom Biosciences use?

Exeliom Biosciences uses 1 known email pattern.

What domain does Exeliom Biosciences use for work emails?

Exeliom Biosciences uses nextbiotix.com for work email addresses.

Most Common Email Formats at Exeliom Biosciences

Exeliom Biosciences's most common email format is FLast@nextbiotix.com (ex. JDoe@nextbiotix.com), used for 100% of nextbiotix.com addresses. Exeliom Biosciences uses 2 email patterns across 2 domains: nextbiotix.com and exeliombio.com. Percentages are the share of addresses within each domain.

@nextbiotix.com

1 pattern

Format	Example	Share of nextbiotix.com
FLast@nextbiotix.comMost common	JDoe@nextbiotix.com	100%

@exeliombio.com

1 pattern

Format	Example	Share of exeliombio.com
FLast@exeliombio.comMost common	JDoe@exeliombio.com	100%

Need a specific person's email?

Browse Exeliom Biosciences's employee directory (about 10 employees) and reveal verified emails free.

Frequently Asked Questions

What does Exeliom Biosciences do?

Exeliom Biosciences was founded in 2016 and operates in the Pharmaceutical Manufacturing industry, alongside similar companies like Medicago. You can visit exeliombio.com. Explore Exeliom Biosciences's company overview page for more information.

What is Exeliom Biosciences's email address format?

Exeliom Biosciences's email format typically follows the pattern of FLast@nextbiotix.com; this email format is used 100% of the time. Other contacts within LeadIQ's database had email formats such as FLast@exeliombio.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Exeliom Biosciences have currently?

Exeliom Biosciences has approximately 10 employees as of October 2026. Key team members to contact include Ceo & Co-Founder: B. H., Chief Operating Officer: M. D. and Co-Founder: H. S. For more team information and contact data, explore Exeliom Biosciences's employee directory with LeadIQ.

Exeliom Biosciences Email Format

Pharmaceutical ManufacturingBourgogne-Franche-Comté, France2-10 Employees

Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies for immuno-oncology and immuno-inflammation. Its candidates are designed to harness microbiome-associated mechanisms that regulate innate immune responses. Based in Dijon, Bourgogne-Franche-Comté, France, the firm operates with a small team. The information provided does not specify a defined customer base or target market. Within the pharmaceutical manufacturing landscape, Exeliom is positioned as a clinical-stage entity advancing its immunotherapy programs. In 2025, the company announced the launch of LIVEDIFF Part 2.

Most common format

FLast@nextbiotix.com

Example: JDoe@nextbiotix.com

2 patterns across 2 domains. See all formats

Verify a Exeliom Biosciences email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at Exeliom Biosciences

@nextbiotix.com

@exeliombio.com

Need a specific person's email?

Frequently Asked Questions

What does Exeliom Biosciences do?

What is Exeliom Biosciences's email address format?

How many employees does Exeliom Biosciences have currently?

Exeliom Biosciences Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.